Ga-68-Trivehexin

N/A

Report date: 2025/11/20 16:00:50
NME

Base Information

Drug NameGa-68-Trivehexin
Drug Alias NameGallium 68 Trivehexin68Ga-TrivehexinRAD-301
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionIntegrin alpha-V/beta-6 antagonists
TargetsIntegrin alpha-V/beta-6
Therapy Area/IndicationsUterine Cervical NeoplasmsEndometrial NeoplasmsCarcinoma, Non-Small-Cell Lung +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTrimt GmbH
China Registration ClassN/A

Develop Information

Active CompaniesRadiopharm Theranostics Ltd
Inactive CompaniesN/A
Active IndicationsUterine Cervical NeoplasmsEndometrial NeoplasmsCarcinoma, Non-Small-Cell Lung +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A